powder FOR THE PROVOCATION OF AIR PASSAGE NARROWING AND/OR THE INDUCTION OF SPUTUM

(19)

(11)

EP 0 748 228 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	25.08.2010 Bulletin 2010/34

(45)	Mention of the grant of the patent:
	21.07.2010 Bulletin 2010/29

(21)	Application number: 95910331.8

(22)	Date of filing: 23.02.1995

(51)

International Patent Classification (IPC):

A61K 33/14^(2006.01)
A61K 9/14^(2006.01)

A61K 31/7004^(2006.01)
A61P 11/10^(2006.01)

(86)	International application number:
	PCT/AU1995/000086

(87)	International publication number:
	WO 1995/022993 (31.08.1995 Gazette 1995/37)

(54)	powder FOR THE PROVOCATION OF AIR PASSAGE NARROWING AND/OR THE INDUCTION OF SPUTUM Pulver FÜR DIE PROVOKATION EINER VERENGUNG DER LUFTWEGE UND/ODER DER SPUTUMPRODUKTION Poudre PERMETTANT D'INDUIRE LE RETRECISSEMENT DES VOIES AERIENNES ET/OU LA PRODUCTION DE crachat

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

25.02.1994 AU PM411494

(43)	Date of publication of application:
	18.12.1996 Bulletin 1996/51

(73)	Proprietor: Sydney South West Area Health Service
	Liverpool NSW 2170 (AU)

(72)	Inventor:
	ANDERSON, Sandra Doreen Birchgrove, NSW 2041 (AU)

(74)	Representative: Cornish, Kristina Victoria Joy et al
	Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ London WC1R 4PJ (GB)

(56)

References cited: :

EP-A- 0 177 783
WO-A-95/28944
DE-A- 3 518 665

WO-A-93/11746
AU-A- 2 746 292

DAVISKAS E ET AL: "Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis." AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, (1999 JUN) 159 (6) 1843-8. , XP002120357
ANDERSON S D ET AL: "The effect of inhaling a dry powder of sodium chloride on the airways of asthmatic subjects." EUROPEAN RESPIRATORY JOURNAL, (1997 NOV) 10 (11) 2465-73. , XP002120358
DAVISKAS E ET AL: "Inhalation of dry - powder mannitol increases mucociliary clearance." EUROPEAN RESPIRATORY JOURNAL, (1997 NOV) 10 (11) 2449-54. , XP002120359
DAVISKAS E. ET AL: "Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects." EUROPEAN RESPIRATORY JOURNAL, (1996) 9/4 (725-732). , XP002120361
DATABASE WPI Week 198737, Derwent Publications Ltd., London, GB; AN 1987-264036 & AU 71645 87 A (CHIESI FARMACEUT SP)
DATABASE WPI Week 199231, Derwent Publications Ltd., London, GB; AN 1992-251539 & AU 11648 92 A (GLAXO)
DATABASE WPI Week 199131, Derwent Publications Ltd., London, GB; AN 1991-225137 & AU 71559 91 A (NATIONAL RES DEV CORP)
REMINGTON'S PHARMACEUTICAL SCIENCES, 17th. Edition 1985, MACK PUBLISHING CO, page 1835 - page 1601.
EUROPEAN JOURNAL OF RESPIRATORY DISEASES,V ol. 66(2), 1985, B.G. SIMONSSON et al., "Acute and Long-term Airway Hyperreactivity in Aluminium-Salt Exposed Workers with Nocturnal Asthma".

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).